Patents by Inventor Dan Bracha

Dan Bracha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220154192
    Abstract: Disclosed is a method and system for the phase separation of folded domains, and more particularly, to inducing clusters of folded domains as part of a drug-based screening application. The system and method utilize one or more first fusion proteins (100, 101), each first fusion protein comprising a first region (110) fused to a second region (120), the first region (110) comprising at least one light sensitive protein (115) or cognate partner of a light sensitive protein (116), and the second region (120) comprising one or more folded RNA binding domains (RBDs), disordered RBDs, folded non-RBD domains, or combination thereof (125).
    Type: Application
    Filed: February 19, 2020
    Publication date: May 19, 2022
    Applicant: The Trustees of Princeton University
    Inventors: Clifford P. Brangwynne, Dan Bracha, Victoria Drake, David W. Sanders
  • Publication number: 20210350875
    Abstract: Disclosed is a high-throughput method and system for mapping or screening biomolecular interactions, where the method includes providing a plurality of cells, or in some examples purified proteins themselves, expressing a phase separation or aggregation system, including those capable of being controlled by at least one wavelength of light, with the phase separation or aggregation system comprising a target protein possibly fused to a fluorescent protein. The cells are placed in a well, and chemical and/or biological agent are then introduced to the well.
    Type: Application
    Filed: September 19, 2019
    Publication date: November 11, 2021
    Applicant: The Trustees of Princeton University
    Inventors: Cliff Brangwynne, Dan Bracha, Chanelle Jumper, Paul Ackerman
  • Publication number: 20210292737
    Abstract: A system and method for reversibly controlling clustering of proteins around an engineered multivalent nucleus is disclosed. The system and method utilize clustering, which may be controlled by light activation or deactivation. The system and method enable the spatiotemporal control of protein supramolecular assemblies, including liquid-like droplets under some conditions, and solid-like gels under other conditions. The system and method can be utilized for segregating or locally concentrating desired proteins and/or RNA in cells or cell lysate, which may be useful for protein purification purposes, or for assembling single or multiple membraneless bodies within specific sub-regions of the cells. These synthetically assembled bodies may recruit both transgenic and endogenic proteins and other biomolecules, thus can be linked to affect and even trigger a plethora of cellular processes, including both physiological and pathological (e.g., protein aggregation) processes.
    Type: Application
    Filed: June 1, 2021
    Publication date: September 23, 2021
    Applicant: The Trustees of Princeton University
    Inventors: Cliff Brangwynne, Dan Bracha
  • Patent number: 11053492
    Abstract: A system and method for reversibly controlling clustering of proteins around an engineered multivalent nucleus is disclosed. The system and method utilize clustering, which may be controlled by light activation or deactivation. The system and method enable the spatiotemporal control of protein supramolecular assemblies, including liquid-like droplets under some conditions, and solid-like gels under other conditions. The system and method can be utilized for segregating or locally concentrating desired proteins and/or RNA in cells or cell lysate, which may be useful for protein purification purposes, or for assembling single or multiple membraneless bodies within specific sub-regions of the cells. These synthetically assembled bodies may recruit both transgenic and endogenic proteins and other biomolecules, thus can be linked to affect and even trigger a plethora of cellular processes, including both physiological and pathological (e.g., protein aggregation) processes.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: July 6, 2021
    Assignee: THE TRUSTEES OF PRINCETON UNIVERSITY
    Inventors: Cliff Brangwynne, Dan Bracha
  • Publication number: 20210047659
    Abstract: Disclosed is a system and method for the controlled clustering of gene regulatory proteins at the specific target genomic loci. The technology enables formation of liquid-like droplets closely interfaced with genome organization. This technology can be utilized for perturbing endogenous nuclear structures as well as nucleating synthetic membrane-less assemblies. The technology can also be utilized for inducing or detecting mechanical stresses within the genome.
    Type: Application
    Filed: January 23, 2019
    Publication date: February 18, 2021
    Applicant: The Trustees of Princeton University
    Inventors: Cliff BRANGWYNNE, Yongdae SHIN, Dan BRACHA
  • Publication number: 20200095569
    Abstract: A system and method for reversibly controlling clustering of proteins around an engineered multivalent nucleus is disclosed. The system and method utilize clustering, which may be controlled by light activation or deactivation. The system and method enable the spatiotemporal control of protein supramolecular assemblies, including liquid-like droplets under some conditions, and solid-like gels under other conditions. The system and method can be utilized for segregating or locally concentrating desired proteins and/or RNA in cells or cell lysate, which may be useful for protein purification purposes, or for assembling single or multiple membraneless bodies within specific sub-regions of the cells. These synthetically assembled bodies may recruit both transgenic and endogenic proteins and other biomolecules, thus can be linked to affect and even trigger a plethora of cellular processes, including both physiological and pathological (e.g., protein aggregation) processes.
    Type: Application
    Filed: December 5, 2019
    Publication date: March 26, 2020
    Applicant: The Trustees of Princeton University
    Inventors: Cliff Brangwynne, Dan Bracha
  • Patent number: 10538756
    Abstract: A system and method for reversibly controlling clustering of proteins around an engineered multivalent nucleus is disclosed. The system and method utilize clustering, which may be controlled by light activation or deactivation. The system and method enable the spatiotemporal control of protein supramolecular assemblies, including liquid-like droplets under some conditions, and solid-like gels under other conditions. The system and method can be utilized for segregating or locally concentrating desired proteins and/or RNA in cells or cell lysate, which may be useful for protein purification purposes, or for assembling single or multiple membraneless bodies within specific sub-regions of the cells. These synthetically assembled bodies may recruit both transgenic and endogenic proteins and other biomolecules, thus can be linked to affect and even trigger a plethora of cellular processes, including both physiological and pathological (e.g., protein aggregation) processes.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: January 21, 2020
    Assignee: THE TRUSTEES OF PRINCETON UNIVERSITY
    Inventors: Cliff Brangwynne, Dan Bracha
  • Publication number: 20180251497
    Abstract: A system and method for reversibly controlling clustering of proteins around an engineered multivalent nucleus is disclosed. The system and method utilize clustering, which may be controlled by light activation or deactivation. The system and method enable the spatiotemporal control of protein supramolecular assemblies, including liquid-like droplets under some conditions, and solid-like gels under other conditions. The system and method can be utilized for segregating or locally concentrating desired proteins and/or RNA in cells or cell lysate, which may be useful for protein purification purposes, or for assembling single or multiple membraneless bodies within specific sub-regions of the cells. These synthetically assembled bodies may recruit both transgenic and endogenic proteins and other biomolecules, thus can be linked to affect and even trigger a plethora of cellular processes.
    Type: Application
    Filed: June 9, 2017
    Publication date: September 6, 2018
    Applicant: The Trustees of Princeton University
    Inventors: Cliff Brangwynne, Dan Bracha